On January 4, 2022 Merck (NYSE: MRK), known as MSD outside the United States and Canada, reported that Robert M. Davis, chief executive officer and president, Dr. Dean Y. Li, president, Merck Research Laboratories, are scheduled to virtually participate in the 40th Annual J.P. Morgan Healthcare Conference on Jan. 10, 2022 at 5:15 p.m. ET (Press release, Merck & Co, JAN 4, 2022, View Source [SID1234598126]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Investors, analysts, members of the media and the general public are invited to watch a live video webcast of the presentations at View Source